Gabapentin
Brand names: Neurontin
Gabapentin is a gabapentinoid used for neuropathic pain and as an adjunct in focal epilepsy.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
US labelling (FDA)
Reference — US labelling, may differ from UK2 DOSAGE AND ADMlNlSTRATION Postherpetic Neuralgia (2.1) Dose can be titrated up as needed to a dose of 1800 mg/day Day 1: Single 300 mg dose Day 2: 600 mg/day (i.e., 300 mg two times a day) Day 3: 900 mg/day (i.e., 300 mg three times a day) Epilepsy with Partial Onset Seizures (2.2) Patients 12 years of age and older: starting dose is 300 mg three times daily; may be titrated up to 600 mg three times daily Patients 3 to 11 years of age: starting dose range is 10 to 15 mg/kg/day, given in three divided doses; recommended dose in patients 3 to 4 years of age is 40 mg/kg/day, given in three divided doses; the recommended dose in patients 5 to 11 years of age is 25 to 35 mg/kg/day, given in …
Source: US FDA prescribing information (openFDA / DailyMed), label dated 2024-04-02. Accessed 2026-06-12. US dosing and indications can differ from UK practice — use UK sources for prescribing decisions.
Clinical monograph
How it works
Gabapentin binds the alpha-2-delta subunit of voltage-gated calcium channels, reducing excitatory neurotransmitter release in sensitised neurons.
Prescribing in practice
- Titrate up gradually to balance efficacy against sedation and dizziness, and taper when stopping rather than stopping abruptly.
- Reduce the dose in renal impairment, as it is cleared renally.
- It is a controlled drug in the UK; be alert to misuse and to additive respiratory depression with opioids or other sedatives.
Monitoring
No routine blood monitoring; review pain or seizure response, sedation, mood, and renal function where relevant.
Counselling the patient
- Drowsiness and dizziness are common at first and usually settle — take care driving until you know how it affects you.
- Do not stop suddenly.
- Tell your clinician about low mood or thoughts of self-harm.
Evidence & guidelines
Gabapentin is a first-line option for neuropathic pain (other than trigeminal neuralgia) per NICE CG173.
Reference: MHRA Drug Safety Update 2019 (Gabapentinoids + opioids); NICE NG193 Neuropathic Pain; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Falls Assessment in Older Adults · NICE CG161 2013
- Anaemia Investigation · BSH / NICE
- Lower Respiratory Tract Infection (Primary Care) · NICE NG138 / NICE antimicrobial guidance
- Hypertension Management · NICE NG136 2019
- Acute Stroke / TIA Assessment · NICE NG128; RCP Stroke Guidelines 2023
- Status Epilepticus (Adults) · NICE CG137; ESEM guidelines; RCP Neurology Guidelines